402 related articles for article (PubMed ID: 15962320)
1. Steatosis: co-factor in other liver diseases.
Powell EE; Jonsson JR; Clouston AD
Hepatology; 2005 Jul; 42(1):5-13. PubMed ID: 15962320
[TBL] [Abstract][Full Text] [Related]
2. Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases.
Powell EE; Jonsson JR; Clouston AD
Dig Dis; 2010; 28(1):186-91. PubMed ID: 20460909
[TBL] [Abstract][Full Text] [Related]
3. Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others.
Clouston AD; Jonsson JR; Powell EE
Clin Liver Dis; 2007 Feb; 11(1):173-89, x. PubMed ID: 17544978
[TBL] [Abstract][Full Text] [Related]
4. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
Castera L
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
[TBL] [Abstract][Full Text] [Related]
5. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
Rafiq N; Younossi ZM
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C and steatosis.
Björnsson E; Angulo P
Arch Med Res; 2007 Aug; 38(6):621-7. PubMed ID: 17613353
[TBL] [Abstract][Full Text] [Related]
7. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury.
Walsh MJ; Vanags DM; Clouston AD; Richardson MM; Purdie DM; Jonsson JR; Powell EE
Hepatology; 2004 May; 39(5):1230-8. PubMed ID: 15122751
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease and hepatitis C infection.
Bondini S; Younossi ZM
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
[TBL] [Abstract][Full Text] [Related]
9. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR; Bhan AK; Zheng H; Chung RT
Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
[TBL] [Abstract][Full Text] [Related]
10. Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C.
Vidali M; Occhino G; Ivaldi A; Rigamonti C; Sartori M; Albano E
Am J Gastroenterol; 2008 Jan; 103(1):147-53. PubMed ID: 18184121
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C and steatosis: a reappraisal.
Lonardo A; Loria P; Adinolfi LE; Carulli N; Ruggiero G
J Viral Hepat; 2006 Feb; 13(2):73-80. PubMed ID: 16436124
[TBL] [Abstract][Full Text] [Related]
12. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
Jansen PL
Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
[TBL] [Abstract][Full Text] [Related]
13. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
14. [Steatosis and hepatitis C].
Testino G
Recenti Prog Med; 2005 Dec; 96(12):621-33; quiz 654. PubMed ID: 16496750
[TBL] [Abstract][Full Text] [Related]
15. [Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?].
Lonardo A; Loria P; Adinolfi LE; Andreana A; Ruggiero G; Carulli N
Ann Ital Med Int; 2005; 20(1):10-22. PubMed ID: 15859390
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C and steatosis.
Monto A
Semin Gastrointest Dis; 2002 Jan; 13(1):40-6. PubMed ID: 11944633
[TBL] [Abstract][Full Text] [Related]
17. Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis.
Bosserhoff A; Hellerbrand C
Dig Dis; 2011; 29(4):377-83. PubMed ID: 21894008
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus-induced hepatocellular steatosis.
Castera L; Chouteau P; Hezode C; Zafrani ES; Dhumeaux D; Pawlotsky JM
Am J Gastroenterol; 2005 Mar; 100(3):711-5. PubMed ID: 15743372
[TBL] [Abstract][Full Text] [Related]
19. Alcohol and hepatitis C.
Safdar K; Schiff ER
Semin Liver Dis; 2004 Aug; 24(3):305-15. PubMed ID: 15349807
[TBL] [Abstract][Full Text] [Related]
20. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
Serfaty L; Lemoine M
Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
